BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21325670)

  • 1. Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.
    Smalberg JH; Kruip MJ; Janssen HL; Rijken DC; Leebeek FW; de Maat MP
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):485-93. PubMed ID: 21325670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thrombophilia in splanchnic vein thrombosis.
    Primignani M; Mannucci PM
    Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
    De Stefano V; Teofili L; Leone G; Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review.
    Shetty S; Ghosh K
    Thromb Res; 2011 Jun; 127(6):505-12. PubMed ID: 20961602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic disorders in abdominal vein thrombosis.
    Leebeek FW; Smalberg JH; Janssen HL
    Neth J Med; 2012 Nov; 70(9):400-5. PubMed ID: 23123534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review.
    Martinelli I; De Stefano V
    Thromb Haemost; 2010 Jun; 103(6):1136-44. PubMed ID: 20352171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired and Heritable Thrombophilia in Indian Patients With Pediatric Deep Venous Thrombosis (DVT).
    Pai N; Ghosh K; Shetty S
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):573-6. PubMed ID: 23406614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thrombosis at unusual sites and the role of thrombophilia.
    Lussana F; Dentali F; Ageno W; Kamphuisen PW
    Semin Thromb Hemost; 2007 Sep; 33(6):582-7. PubMed ID: 17768690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited and acquired risk factors for venous thromboembolism.
    Baglin T
    Semin Respir Crit Care Med; 2012 Apr; 33(2):127-37. PubMed ID: 22648484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.
    Denninger MH; Helley D; Valla D; Guillin MC
    Thromb Haemost; 1997 Oct; 78(4):1297-8. PubMed ID: 9365003
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.
    Tondeur S; Boutruche S; Biron-Andréani C; Schved JF
    Thromb Haemost; 2009 Apr; 101(4):787-9. PubMed ID: 19350131
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.
    Fiorini A; Chiusolo P; Rossi E; Za T; De Ritis DG; Ciminello A; Leone G; De Stefano V
    Am J Hematol; 2009 Feb; 84(2):126-7. PubMed ID: 19105231
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population - results from FLAER-based flowcytometry screening.
    Ahluwalia J; Naseem S; Sachdeva MU; Bose P; Bose SK; Kumar N; Thapa BR; Varma N; Chawla YK
    Eur J Haematol; 2014; 92(5):435-43. PubMed ID: 24400962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
    Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
    Mohanty D; Shetty S; Ghosh K; Pawar A; Abraham P
    Hepatology; 2001 Oct; 34(4 Pt 1):666-70. PubMed ID: 11584361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
    Brière JB
    Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for thrombosis in cancer patients.
    Ashrani AA; Heit JA
    Cancer Treat Res; 2009; 148():95-114. PubMed ID: 19377921
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.